カテゴリー： QYResearch, 世界, 部品/材料

世界の医療用L-カルノシン市場インサイト及び予測（純度98％以上、純度99％以上）

◆英語タイトル：Global L-Carnosine for Healthcare Market Insights, Forecast to 2028

QYResearchが発行した調査報告書（QY22JLX01358）◆商品コード：QY22JLX01358
◆発行会社（リサーチ会社）：QYResearch
◆発行日：2022年7月（※2025年版があります。お問い合わせください。）
◆ページ数：96
◆レポート形式：英語 / PDF
◆納品方法：Eメール（受注後3営業日）
◆調査対象地域：グローバル
◆産業分野：化学＆材料
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD4,900 ⇒換算￥725,200見積依頼/購入/質問フォーム
Multi User（5名様閲覧用）USD7,350 ⇒換算￥1,087,800見積依頼/購入/質問フォーム
Enterprise License（同一法人内共有可）USD9,800 ⇒換算￥1,450,400見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いに変更可）
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。

❖ レポートの概要 ❖

COVID-19のパンデミックにより、医療用L-カルノシンのグローバル市場規模は2022年にUS$xxxと推定され、調査期間中のCAGRはxxx％で、2028年までに再調整された規模はUS$xxxになると予測されています。この医療危機による経済変化を十分に考慮すると、2021年に医療用L-カルノシンの世界市場のxxx％を占める「純度98％以上」タイプは、2028年までにUS$xxxの規模になり、パンデミック後の修正xxx％CAGRで成長すると予測されています。一方、「栄養補助食品」セグメントは、この予測期間を通じてxxx％のCAGRに変更されます。
医療用L-カルノシンの中国市場規模は2021年にUS$xxxと分析されており、米国とヨーロッパの市場規模はそれぞれUS$xxxとUS$xxxです。米国の割合は2021年にxxx％であり、中国とヨーロッパはそれぞれxxx％とxxx％です。中国の割合は2028年にxxx％に達し、対象期間を通じてxxx％のCAGRを記録すると予測されています。日本、韓国、東南アジアはアジアで注目市場であり、今後6年間のCAGRはそれぞれxxx％、xxx％、xxx％になる見通しです。ヨーロッパの医療用L-カルノシン市場については、ドイツは2028年までにUS$xxxに達すると予測されており、予測期間中のCAGRはxxx％になる見通しです。

医療用L-カルノシンのグローバル主要企業には、Fushilai Pharmaceutical、Hamari Chemicals、Sinoway Industrial、Xi'an Miracle Biotechnology、Belle Chemical、SUANFARMAなどがあります。2021年、世界のトップ5プレイヤーは売上ベースで約xxx％の市場シェアを占めています。

医療用L-カルノシン市場は、種類と用途によって区分されます。世界の医療用L-カルノシン市場のプレーヤー、利害関係者、およびその他の参加者は、当レポートを有益なリソースとして使用することで優位に立つことができます。セグメント分析は、2017年～2028年期間のタイプ別および用途別の販売量、売上、予測に焦点を当てています。

【種類別セグメント】
純度98％以上、純度99％以上

【用途別セグメント】
栄養補助食品、医薬品

【掲載地域】
北米：アメリカ、カナダ
ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア
アジア太平洋：日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア
中南米：メキシコ、ブラジル、アルゼンチン
中東・アフリカ：トルコ、サウジアラビア、UAE

【目次（一部）】

・調査の範囲
- 医療用L-カルノシン製品概要
- 種類別市場（純度98％以上、純度99％以上）
- 用途別市場（栄養補助食品、医薬品）
- 調査の目的
・エグゼクティブサマリー
- 世界の医療用L-カルノシン販売量予測2017-2028
- 世界の医療用L-カルノシン売上予測2017-2028
- 医療用L-カルノシンの地域別販売量
- 医療用L-カルノシンの地域別売上
- 北米市場
- ヨーロッパ市場
- アジア太平洋市場
- 中南米市場
- 中東・アフリカ市場
・メーカーの競争状況
- 主要メーカー別医療用L-カルノシン販売量
- 主要メーカー別医療用L-カルノシン売上
- 主要メーカー別医療用L-カルノシン価格
- 競争状況の分析
- 企業M&A動向
・種類別市場規模（純度98％以上、純度99％以上）
- 医療用L-カルノシンの種類別販売量
- 医療用L-カルノシンの種類別売上
- 医療用L-カルノシンの種類別価格
・用途別市場規模（栄養補助食品、医薬品）
- 医療用L-カルノシンの用途別販売量
- 医療用L-カルノシンの用途別売上
- 医療用L-カルノシンの用途別価格
・北米市場
- 北米の医療用L-カルノシン市場規模（種類別、用途別）
- 主要国別の医療用L-カルノシン市場規模（アメリカ、カナダ）
・ヨーロッパ市場
- ヨーロッパの医療用L-カルノシン市場規模（種類別、用途別）
- 主要国別の医療用L-カルノシン市場規模（ドイツ、フランス、イギリス、イタリア、ロシア）
・アジア太平洋市場
- アジア太平洋の医療用L-カルノシン市場規模（種類別、用途別）
- 主要国別の医療用L-カルノシン市場規模（日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア）
・中南米市場
- 中南米の医療用L-カルノシン市場規模（種類別、用途別）
- 主要国別の医療用L-カルノシン市場規模（メキシコ、ブラジル、アルゼンチン）
・中東・アフリカ市場
- 中東・アフリカの医療用L-カルノシン市場規模（種類別、用途別）
- 主要国別の医療用L-カルノシン市場規模（トルコ、サウジアラビア）
・企業情報
Fushilai Pharmaceutical、Hamari Chemicals、Sinoway Industrial、Xi'an Miracle Biotechnology、Belle Chemical、SUANFARMA
・産業チェーン及び販売チャネル分析
- 医療用L-カルノシンの産業チェーン分析
- 医療用L-カルノシンの原材料
- 医療用L-カルノシンの生産プロセス
- 医療用L-カルノシンの販売及びマーケティング
- 医療用L-カルノシンの主要顧客
・マーケットドライバー、機会、課題、リスク要因分析
- 医療用L-カルノシンの産業動向
- 医療用L-カルノシンのマーケットドライバー
- 医療用L-カルノシンの課題
- 医療用L-カルノシンの阻害要因
・主な調査結果

Market Analysis and Insights: Global L-Carnosine for Healthcare Market
Due to the COVID-19 pandemic, the global L-Carnosine for Healthcare market size is estimated to be worth US$ million in 2022 and is forecast to a readjusted size of US$ million by 2028 with a CAGR of % during the forecast period 2022-2028. Fully considering the economic change by this health crisis, Purity Above 98% accounting for % of the L-Carnosine for Healthcare global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR from 2022 to 2028. While Dietary Supplements segment is altered to an % CAGR throughout this forecast period.
China L-Carnosine for Healthcare market size is valued at US$ million in 2021, while the US and Europe L-Carnosine for Healthcare are US$ million and US$ million, severally. The proportion of the US is % in 2021, while China and Europe are % and % respectively, and it is predicted that China proportion will reach % in 2028, trailing a CAGR of % through the analysis period 2022-2028. Japan, South Korea, and Southeast Asia are noteworthy markets in Asia, with CAGR %, %, and % respectively for the next 6-year period. As for the Europe L-Carnosine for Healthcare landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period 2022-2028.
The global key manufacturers of L-Carnosine for Healthcare include Fushilai Pharmaceutical, Hamari Chemicals, Sinoway Industrial, Xi’an Miracle Biotechnology, Belle Chemical and SUANFARMA, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
In terms of production side, this report researches the L-Carnosine for Healthcare capacity, production, growth rate, market share by manufacturers and by region (region level and country level), from 2017 to 2022, and forecast to 2028.
In terms of sales side, this report focuses on the sales of L-Carnosine for Healthcare by region (region level and country level), by company, by Type and by Application. from 2017 to 2022 and forecast to 2028.
Global L-Carnosine for Healthcare Scope and Segment
L-Carnosine for Healthcare market is segmented by Type and by Application. Players, stakeholders, and other participants in the global L-Carnosine for Healthcare market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on production capacity, revenue and forecast by Type and by Application for the period 2017-2028.
Segment by Type
Purity Above 98%
Purity Above 99%
Segment by Application
Dietary Supplements
Pharmaceutical
By Company
Fushilai Pharmaceutical
Hamari Chemicals
Sinoway Industrial
Xi’an Miracle Biotechnology
Belle Chemical
SUANFARMA
Production by Region
North America
Europe
China
Japan
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE

❖ レポートの目次 ❖

1 Study Coverage
1.1 L-Carnosine for Healthcare Product Introduction
1.2 Market by Type
1.2.1 Global L-Carnosine for Healthcare Market Size by Type, 2017 VS 2021 VS 2028
1.2.2 Purity Above 98%
1.2.3 Purity Above 99%
1.3 Market by Application
1.3.1 Global L-Carnosine for Healthcare Market Size by Application, 2017 VS 2021 VS 2028
1.3.2 Dietary Supplements
1.3.3 Pharmaceutical
1.4 Study Objectives
1.5 Years Considered
2 Global L-Carnosine for Healthcare Production
2.1 Global L-Carnosine for Healthcare Production Capacity (2017-2028)
2.2 Global L-Carnosine for Healthcare Production by Region: 2017 VS 2021 VS 2028
2.3 Global L-Carnosine for Healthcare Production by Region
2.3.1 Global L-Carnosine for Healthcare Historic Production by Region (2017-2022)
2.3.2 Global L-Carnosine for Healthcare Forecasted Production by Region (2023-2028)
2.4 North America
2.5 Europe
2.6 China
2.7 Japan
3 Global L-Carnosine for Healthcare Sales in Volume & Value Estimates and Forecasts
3.1 Global L-Carnosine for Healthcare Sales Estimates and Forecasts 2017-2028
3.2 Global L-Carnosine for Healthcare Revenue Estimates and Forecasts 2017-2028
3.3 Global L-Carnosine for Healthcare Revenue by Region: 2017 VS 2021 VS 2028
3.4 Global L-Carnosine for Healthcare Sales by Region
3.4.1 Global L-Carnosine for Healthcare Sales by Region (2017-2022)
3.4.2 Global Sales L-Carnosine for Healthcare by Region (2023-2028)
3.5 Global L-Carnosine for Healthcare Revenue by Region
3.5.1 Global L-Carnosine for Healthcare Revenue by Region (2017-2022)
3.5.2 Global L-Carnosine for Healthcare Revenue by Region (2023-2028)
3.6 North America
3.7 Europe
3.8 Asia-Pacific
3.9 Latin America
3.10 Middle East & Africa
4 Competition by Manufactures
4.1 Global L-Carnosine for Healthcare Production Capacity by Manufacturers
4.2 Global L-Carnosine for Healthcare Sales by Manufacturers
4.2.1 Global L-Carnosine for Healthcare Sales by Manufacturers (2017-2022)
4.2.2 Global L-Carnosine for Healthcare Sales Market Share by Manufacturers (2017-2022)
4.2.3 Global Top 10 and Top 5 Largest Manufacturers of L-Carnosine for Healthcare in 2021
4.3 Global L-Carnosine for Healthcare Revenue by Manufacturers
4.3.1 Global L-Carnosine for Healthcare Revenue by Manufacturers (2017-2022)
4.3.2 Global L-Carnosine for Healthcare Revenue Market Share by Manufacturers (2017-2022)
4.3.3 Global Top 10 and Top 5 Companies by L-Carnosine for Healthcare Revenue in 2021
4.4 Global L-Carnosine for Healthcare Sales Price by Manufacturers
4.5 Analysis of Competitive Landscape
4.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
4.5.2 Global L-Carnosine for Healthcare Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.5.3 Global L-Carnosine for Healthcare Manufacturers Geographical Distribution
4.6 Mergers & Acquisitions, Expansion Plans
5 Market Size by Type
5.1 Global L-Carnosine for Healthcare Sales by Type
5.1.1 Global L-Carnosine for Healthcare Historical Sales by Type (2017-2022)
5.1.2 Global L-Carnosine for Healthcare Forecasted Sales by Type (2023-2028)
5.1.3 Global L-Carnosine for Healthcare Sales Market Share by Type (2017-2028)
5.2 Global L-Carnosine for Healthcare Revenue by Type
5.2.1 Global L-Carnosine for Healthcare Historical Revenue by Type (2017-2022)
5.2.2 Global L-Carnosine for Healthcare Forecasted Revenue by Type (2023-2028)
5.2.3 Global L-Carnosine for Healthcare Revenue Market Share by Type (2017-2028)
5.3 Global L-Carnosine for Healthcare Price by Type
5.3.1 Global L-Carnosine for Healthcare Price by Type (2017-2022)
5.3.2 Global L-Carnosine for Healthcare Price Forecast by Type (2023-2028)
6 Market Size by Application
6.1 Global L-Carnosine for Healthcare Sales by Application
6.1.1 Global L-Carnosine for Healthcare Historical Sales by Application (2017-2022)
6.1.2 Global L-Carnosine for Healthcare Forecasted Sales by Application (2023-2028)
6.1.3 Global L-Carnosine for Healthcare Sales Market Share by Application (2017-2028)
6.2 Global L-Carnosine for Healthcare Revenue by Application
6.2.1 Global L-Carnosine for Healthcare Historical Revenue by Application (2017-2022)
6.2.2 Global L-Carnosine for Healthcare Forecasted Revenue by Application (2023-2028)
6.2.3 Global L-Carnosine for Healthcare Revenue Market Share by Application (2017-2028)
6.3 Global L-Carnosine for Healthcare Price by Application
6.3.1 Global L-Carnosine for Healthcare Price by Application (2017-2022)
6.3.2 Global L-Carnosine for Healthcare Price Forecast by Application (2023-2028)
7 North America
7.1 North America L-Carnosine for Healthcare Market Size by Type
7.1.1 North America L-Carnosine for Healthcare Sales by Type (2017-2028)
7.1.2 North America L-Carnosine for Healthcare Revenue by Type (2017-2028)
7.2 North America L-Carnosine for Healthcare Market Size by Application
7.2.1 North America L-Carnosine for Healthcare Sales by Application (2017-2028)
7.2.2 North America L-Carnosine for Healthcare Revenue by Application (2017-2028)
7.3 North America L-Carnosine for Healthcare Sales by Country
7.3.1 North America L-Carnosine for Healthcare Sales by Country (2017-2028)
7.3.2 North America L-Carnosine for Healthcare Revenue by Country (2017-2028)
7.3.3 United States
7.3.4 Canada
8 Europe
8.1 Europe L-Carnosine for Healthcare Market Size by Type
8.1.1 Europe L-Carnosine for Healthcare Sales by Type (2017-2028)
8.1.2 Europe L-Carnosine for Healthcare Revenue by Type (2017-2028)
8.2 Europe L-Carnosine for Healthcare Market Size by Application
8.2.1 Europe L-Carnosine for Healthcare Sales by Application (2017-2028)
8.2.2 Europe L-Carnosine for Healthcare Revenue by Application (2017-2028)
8.3 Europe L-Carnosine for Healthcare Sales by Country
8.3.1 Europe L-Carnosine for Healthcare Sales by Country (2017-2028)
8.3.2 Europe L-Carnosine for Healthcare Revenue by Country (2017-2028)
8.3.3 Germany
8.3.4 France
8.3.5 U.K.
8.3.6 Italy
8.3.7 Russia
9 Asia Pacific
9.1 Asia Pacific L-Carnosine for Healthcare Market Size by Type
9.1.1 Asia Pacific L-Carnosine for Healthcare Sales by Type (2017-2028)
9.1.2 Asia Pacific L-Carnosine for Healthcare Revenue by Type (2017-2028)
9.2 Asia Pacific L-Carnosine for Healthcare Market Size by Application
9.2.1 Asia Pacific L-Carnosine for Healthcare Sales by Application (2017-2028)
9.2.2 Asia Pacific L-Carnosine for Healthcare Revenue by Application (2017-2028)
9.3 Asia Pacific L-Carnosine for Healthcare Sales by Region
9.3.1 Asia Pacific L-Carnosine for Healthcare Sales by Region (2017-2028)
9.3.2 Asia Pacific L-Carnosine for Healthcare Revenue by Region (2017-2028)
9.3.3 China
9.3.4 Japan
9.3.5 South Korea
9.3.6 India
9.3.7 Australia
9.3.8 China Taiwan
9.3.9 Indonesia
9.3.10 Thailand
9.3.11 Malaysia
10 Latin America
10.1 Latin America L-Carnosine for Healthcare Market Size by Type
10.1.1 Latin America L-Carnosine for Healthcare Sales by Type (2017-2028)
10.1.2 Latin America L-Carnosine for Healthcare Revenue by Type (2017-2028)
10.2 Latin America L-Carnosine for Healthcare Market Size by Application
10.2.1 Latin America L-Carnosine for Healthcare Sales by Application (2017-2028)
10.2.2 Latin America L-Carnosine for Healthcare Revenue by Application (2017-2028)
10.3 Latin America L-Carnosine for Healthcare Sales by Country
10.3.1 Latin America L-Carnosine for Healthcare Sales by Country (2017-2028)
10.3.2 Latin America L-Carnosine for Healthcare Revenue by Country (2017-2028)
10.3.3 Mexico
10.3.4 Brazil
10.3.5 Argentina
10.3.6 Colombia
11 Middle East and Africa
11.1 Middle East and Africa L-Carnosine for Healthcare Market Size by Type
11.1.1 Middle East and Africa L-Carnosine for Healthcare Sales by Type (2017-2028)
11.1.2 Middle East and Africa L-Carnosine for Healthcare Revenue by Type (2017-2028)
11.2 Middle East and Africa L-Carnosine for Healthcare Market Size by Application
11.2.1 Middle East and Africa L-Carnosine for Healthcare Sales by Application (2017-2028)
11.2.2 Middle East and Africa L-Carnosine for Healthcare Revenue by Application (2017-2028)
11.3 Middle East and Africa L-Carnosine for Healthcare Sales by Country
11.3.1 Middle East and Africa L-Carnosine for Healthcare Sales by Country (2017-2028)
11.3.2 Middle East and Africa L-Carnosine for Healthcare Revenue by Country (2017-2028)
11.3.3 Turkey
11.3.4 Saudi Arabia
11.3.5 UAE
12 Corporate Profiles
12.1 Fushilai Pharmaceutical
12.1.1 Fushilai Pharmaceutical Corporation Information
12.1.2 Fushilai Pharmaceutical Overview
12.1.3 Fushilai Pharmaceutical L-Carnosine for Healthcare Sales, Price, Revenue and Gross Margin (2017-2022)
12.1.4 Fushilai Pharmaceutical L-Carnosine for Healthcare Product Model Numbers, Pictures, Descriptions and Specifications
12.1.5 Fushilai Pharmaceutical Recent Developments
12.2 Hamari Chemicals
12.2.1 Hamari Chemicals Corporation Information
12.2.2 Hamari Chemicals Overview
12.2.3 Hamari Chemicals L-Carnosine for Healthcare Sales, Price, Revenue and Gross Margin (2017-2022)
12.2.4 Hamari Chemicals L-Carnosine for Healthcare Product Model Numbers, Pictures, Descriptions and Specifications
12.2.5 Hamari Chemicals Recent Developments
12.3 Sinoway Industrial
12.3.1 Sinoway Industrial Corporation Information
12.3.2 Sinoway Industrial Overview
12.3.3 Sinoway Industrial L-Carnosine for Healthcare Sales, Price, Revenue and Gross Margin (2017-2022)
12.3.4 Sinoway Industrial L-Carnosine for Healthcare Product Model Numbers, Pictures, Descriptions and Specifications
12.3.5 Sinoway Industrial Recent Developments
12.4 Xi’an Miracle Biotechnology
12.4.1 Xi’an Miracle Biotechnology Corporation Information
12.4.2 Xi’an Miracle Biotechnology Overview
12.4.3 Xi’an Miracle Biotechnology L-Carnosine for Healthcare Sales, Price, Revenue and Gross Margin (2017-2022)
12.4.4 Xi’an Miracle Biotechnology L-Carnosine for Healthcare Product Model Numbers, Pictures, Descriptions and Specifications
12.4.5 Xi’an Miracle Biotechnology Recent Developments
12.5 Belle Chemical
12.5.1 Belle Chemical Corporation Information
12.5.2 Belle Chemical Overview
12.5.3 Belle Chemical L-Carnosine for Healthcare Sales, Price, Revenue and Gross Margin (2017-2022)
12.5.4 Belle Chemical L-Carnosine for Healthcare Product Model Numbers, Pictures, Descriptions and Specifications
12.5.5 Belle Chemical Recent Developments
12.6 SUANFARMA
12.6.1 SUANFARMA Corporation Information
12.6.2 SUANFARMA Overview
12.6.3 SUANFARMA L-Carnosine for Healthcare Sales, Price, Revenue and Gross Margin (2017-2022)
12.6.4 SUANFARMA L-Carnosine for Healthcare Product Model Numbers, Pictures, Descriptions and Specifications
12.6.5 SUANFARMA Recent Developments
13 Industry Chain and Sales Channels Analysis
13.1 L-Carnosine for Healthcare Industry Chain Analysis
13.2 L-Carnosine for Healthcare Key Raw Materials
13.2.1 Key Raw Materials
13.2.2 Raw Materials Key Suppliers
13.3 L-Carnosine for Healthcare Production Mode & Process
13.4 L-Carnosine for Healthcare Sales and Marketing
13.4.1 L-Carnosine for Healthcare Sales Channels
13.4.2 L-Carnosine for Healthcare Distributors
13.5 L-Carnosine for Healthcare Customers
14 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
14.1 L-Carnosine for Healthcare Industry Trends
14.2 L-Carnosine for Healthcare Market Drivers
14.3 L-Carnosine for Healthcare Market Challenges
14.4 L-Carnosine for Healthcare Market Restraints
15 Key Finding in The Global L-Carnosine for Healthcare Study
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer



❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer
★リサーチレポート[ 世界の医療用L-カルノシン市場インサイト及び予測（純度98％以上、純度99％以上）(Global L-Carnosine for Healthcare Market Insights, Forecast to 2028)]についてメールでお問い合わせはこちらでお願いします。
◆関連リサーチレポート◆
  • 世界のカリウムシリコフルオリド市場インサイト及び予測（純度98％、純度99％、純度99.9％、その他）
  • 世界のHEPESバッファー市場インサイト及び予測（純度98％、純度99％、純度99.5％）
  • 世界の2-エチルブタナール市場インサイト及び予測（純度98％以下、純度98％〜99％、純度99％以上）
  • 世界のHEPES溶液市場インサイト及び予測（純度98％、純度99％、純度99.5％）
  • 世界の2-エチル酪酸市場インサイト及び予測（純度98％以下、純度98％〜99％、純度99％以上）